LENZ Therapeutics Inc (LENZ)
15.29
-0.22
(-1.42%)
USD |
NASDAQ |
May 31, 16:00
15.30
+0.01
(+0.07%)
After-Hours: 20:00
LENZ Therapeutics Cash from Financing (Quarterly): 171.27M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 171.27M |
| September 30, 2023 | 82.61M |
| Date | Value |
|---|---|
| March 31, 2023 | 83.18M |
| September 30, 2022 | 10.01M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
10.01M
Minimum
Sep 2022
171.27M
Maximum
Mar 2024
86.77M
Average
82.90M
Median
Cash from Financing (Quarterly) Benchmarks
| TruBridge Inc | -14.05M |
| PetMed Express Inc | -0.015M |
| Streamline Health Solutions Inc | 0.699M |
| R1 RCM Inc | 656.10M |
| MoonLake Immunotherapeutics | 50.98M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.94M |
| Cash from Investing (Quarterly) | 18.00M |
| Free Cash Flow | -72.77M |
| Free Cash Flow Per Share (Quarterly) | -5.074 |
| Free Cash Flow Yield | -23.41% |